Morgan Stanley
SMTI icon

Morgan Stanley’s Sanara MedTech SMTI Stock Holding History

Morgan Stanley’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$557K Buy
23,628
+3,988
+20% +$82.5K ﹤0.01% 5498
2026
Q1 		$337K Sell
19,640
-8,587
-30% -$177K ﹤0.01% 5663
2025
Q4 		$659K Buy
28,227
+10,210
+57% +$264K ﹤0.01% 5376
2025
Q3 		$572K Sell
18,017
-3,096
-15% -$93.5K ﹤0.01% 5446
2025
Q2 		$599K Buy
21,113
+5,049
+31% +$151K ﹤0.01% 5379
2025
Q1 		$496K Buy
16,064
+2,288
+17% +$77.7K ﹤0.01% 5327
2024
Q4 		$457K Buy
13,776
+796
+6% +$27K ﹤0.01% 5455
2024
Q3 		$393K Buy
12,980
+5,744
+79% +$179K ﹤0.01% 5510
2024
Q2 		$204K Sell
7,236
-1,052
-13% -$33K ﹤0.01% 5665
2024
Q1 		$307K Sell
8,288
-12,490
-60% -$467K ﹤0.01% 5543
2023
Q4 		$854K Buy
20,778
+15,794
+317% +$507K ﹤0.01% 5376
2023
Q3 		$155K Sell
4,984
-1,104
-18% -$42.8K ﹤0.01% 5696
2023
Q2 		$244K Sell
6,088
-3,954
-39% -$162K ﹤0.01% 5555
2023
Q1 		$414K Buy
10,042
+4,907
+96% +$207K ﹤0.01% 5359
2022
Q4 		$234K Buy
5,135
+1,900
+59% +$65.5K ﹤0.01% 5601
2022
Q3 		$96K Buy
3,235
+2,044
+172% +$57.2K ﹤0.01% 6096
2022
Q2 		$25K Sell
1,191
-806
-40% -$18.8K ﹤0.01% 6903
2022
Q1 		$56K Sell
1,997
-3,675
-65% -$93.2K ﹤0.01% 6649
2021
Q4 		$167K Buy
5,672
+1,421
+33% +$44.7K ﹤0.01% 6156
2021
Q3 		$146K Buy
4,251
+3,856
+976% +$138K ﹤0.01% 6164
2021
Q2 		$15K Buy
+395
New +$11.5K ﹤0.01% 7107

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Morgan Stanley's SMTI Position: Q2 2026 in Review

Morgan Stanley increased its Sanara MedTech (SMTI) stake by 20% in Q2 2026, buying an estimated $82.5K and bringing the position to 23,628 shares worth $557K. The position accounts for ﹤0.01% of the portfolio, ranked #5498.

Morgan Stanley first reported a position in SMTI in Q2 2021 and has held it in 21 quarters since. The position peaked at $854K in Q4 2023. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Morgan Stanley held 23,628 shares of Sanara MedTech worth $557K as of Q2 2026.
  • Morgan Stanley bought 3,988 Sanara MedTech shares in Q2 2026, an estimated $82.5K.
  • Sanara MedTech made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5498 holding.
  • Morgan Stanley first reported a position in Sanara MedTech in Q2 2021 and has held it in 21 quarters since.
  • Morgan Stanley's Sanara MedTech position peaked at $854K in Q4 2023.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.